海外の治験の状況「COVID-19」での検索結果
40件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Not recruiting
- RIMAG Study: Trial of Rituximab Versus Placebo in Polyneuropathy Associated With Anti-MAG IgM Monoclonal Gammopathy
- Polyneuropathy
- France
- 2005-11-29
Not recruiting
- Addition of Aromatase at the Navelbine in Pretreated Metastatic Breast Cancer.
- Breast Cancer;Breast Cancer;Breast Cancer;Breast Cancer
- France
- 2015-10-22
Not Recruiting
- A study to measure pretection (antibody response) and safety against representative strains causing a high proportion of disease (Meningococcal Group B) in healthy subject aged between 12 and 19 years.
- Test the safety and immunogenicity of Bexsero used as a vaccine for Neisseria meningitidis MedDRA version: 18.0 Level: PT Classification code 10027249 Term: Meningitis meningococcal System Organ Class: 10021881 - Infections and infestations ;Therapeutic area: Diseases [C] - Bacterial Infections and Mycoses [C01]
- Denmark
- 2014-11-26
Not Recruiting
- A randomized, double blinded placebo controlled study to investigate antimicrobial efficacy and safety following topical application of DPK-060. Final protocol dated 2007-12-19. CRO protocol no. Q-27318. Final protocol incorporating amendment 1 dated 2008-08-28. Amendment 2 dated 2008-10-01.
- Atopic dermatitis
- Sweden
- 2008-01-02
Not recruiting
- Comparison of 22-gauge and 19-gauge Aspiration Needle During EBUS-TBNA
- Lung Cancer
- Germany, Switzerland
- 2016-06-16
Not recruiting
- Tamoxifen-RAD001 Versus Tamoxifen Alone in Patients With Anti-aromatase Resistant Breast Metastatic Cancer
- Breast Neoplasms;mTor Protein
- France
- 2011-02-16
Not Recruiting
- The effect of Nandrolone Decanoate Injection and Leucine Supplementation on Muscle Loss During Immobilisation
- muscle atrophy
- The Netherlands
- 2015-07-02
Not recruiting
- The Effect of Nandrolone Decanoate and Leucine on Muscle Loss
- Muscle Atrophy;Muscle Atrophy;Muscle Atrophy;Muscle Atrophy
- Netherlands
- 2015-02-19
Not Recruiting
- Studies on the gastrointestinal hormone fibroblast growth factor 19 (FGF19) in overweight and obese patients with non-alcoholic fatty liver diseases (NAFLD)
- ;K76.0 - Fatty (change of) liver, not elsewhere classified;E66.0 - Obesity due to excess calories
- Germany
- 2018-01-30
Not recruiting
- CD56+CD3- NK Cells Following Allogeneic Stem Cell Transplantation
- Haematological Malignancies;Allogeneic Stem Cell Transplant;CD56+CD3- NK Cells
- United Kingdom
- 2011-03-22